PJ

Peddi Jagadishwar

Active Director Director DIN 00071114
DIN 00071114 First appointment Mar 2006 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 2 active board seats
Past companies 2 historical roles
Total affiliations 4 Since Mar 2006
Shareholding value •••• Premium profile

About Peddi Jagadishwar

Data last updated:

Peddi Jagadishwar is a Director at Sri Anantha Padmanabha Swamy Pharma Private Limited (since 2013) and Director at Sj Life Sciences Private Limited (since 2020). The companies operate in Pharma. The 2 current companies with reported revenue have a combined latest revenue of ₹15.21 Cr; the largest is Sri Anantha Padmanabha Swamy Pharma Private Limited at ₹8.58 Cr (FY 2024). Earlier, Peddi Jagadishwar was a Director at Mania Pharma Private Limited (from 2008) and Managing Director at Elixir Therapeutics Private Limited (from 2006).

DIN 00071114
Primary Designation Director
Industry Pharma
First Appointment 02 Mar 2006
Oldest Company Age 20 yrs
Largest company Sri Anantha Padmanabha Swamy Pharma Private Limited · ₹8.58 Cr (FY 2024)
Combined revenue ₹15.21 Cr across 2 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director07 Apr 20132013₹8.58 Cr (FY 2024)Active
Sj Life Sciences Private Limited U51909TG2020PTC144174
Director23 Sep 20202020₹6.63 Cr (FY 2025)Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Mania Pharma Private Limited U24233TG2008PTC059751
Director20 Jun 20082008Strike Off
Elixir Therapeutics Private Limited U24239TG2006PTC049366
Managing Director02 Mar 20062006Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Mania Pharma Private Limited
Elixir Therapeutics Private Limited
Sj Life Sciences Private Limited
Sri Anantha Padmanabha Swamy Pharma Private Limited
Premium access

Shareholding and investment profile for Peddi Jagadishwar

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Peddi Jagadishwar

Peddi Jagadishwar currently holds 2 directorships: Sri Anantha Padmanabha Swamy Pharma Private Limited (Director, since 07 Apr 2013, revenue ₹8.58 Cr (FY 2024)); Sj Life Sciences Private Limited (Director, since 23 Sep 2020, revenue ₹6.63 Cr (FY 2025)).

Peddi Jagadishwar was first appointed on 02 Mar 2006 as Managing Director at Elixir Therapeutics Private Limited. The most recent appointment on record is 23 Sep 2020 at Sj Life Sciences Private Limited.

The 2 current companies of Peddi Jagadishwar that report revenue have a combined latest revenue of ₹15.21 Cr: Sri Anantha Padmanabha Swamy Pharma Private Limited ₹8.58 Cr (FY 2024); Sj Life Sciences Private Limited ₹6.63 Cr (FY 2025).

Peddi Jagadishwar held 2 earlier board appointments: Mania Pharma Private Limited (Director, from 20 Jun 2008); Elixir Therapeutics Private Limited (Managing Director, from 02 Mar 2006).

The current boards of Peddi Jagadishwar's companies include Alok Agarwal (Sri Anantha Padmanabha Swamy Pharma Private Limited), Bhaskar Karshikallam (Sri Anantha Padmanabha Swamy Pharma Private Limited), Naresh Kumar Peddi (Sri Anantha Padmanabha Swamy Pharma Private Limited), Renu Goyal (Sri Anantha Padmanabha Swamy Pharma Private Limited), Vallabadas Satyanarayana Goud (Sri Anantha Padmanabha Swamy Pharma Private Limited), Peddi Naveen Kumar (Sj Life Sciences Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available